Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors

[cafead]

via Adeno-associated viruses have become popular vectors for the delivery of gene therapies. But, despite their relatively safe profile, they can trigger some unwanted immune responses, which may reduce treatment efficacy or, worse, cause serious side effects.

article source